Serum fetuin-A concentration and endothelial dysfunction in chronic kidney disease

Nephron - Clinical Practice

Volumn 108, Issue 3, 2008, Pages

  Caglar, Kayser ^a   Yilmaz, Mahmut Ilker ^a,c   Saglam, Mutlu ^a   Cakir, Erdinc ^a   Kilic, Selim ^a   Sonmez, Alper ^a   Eyileten, Tayfun ^a   Yenicesu, Mujdat ^a   Oguz, Yusuf ^a   Tasar, Mustafa ^a   Vural, Abdulgaffar ^a   Ikizler, T Alp ^b   Stenvinkel, Peter ^c   Lindholm, Bengt ^c  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chronic kidney disease; Endothelial dysfunction; Fetuin A; Flow mediated dilatation

Indexed keywords

FETUIN A; PARATHYROID HORMONE;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; CAROTID ARTERY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE COURSE; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; STATISTICAL SIGNIFICANCE;

ADULT; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; BLOOD PROTEINS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE;

EID: 42549095082     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000120209     Document Type: Article

References (32)

1. Levey AS, Eknoyan G: Cardiovascular disease in chronic renal disease. Nephrol Dial Transplant 1999;14:828-833.
2. Zoccali C, Mallamaci M, Tripepi G: Novel cardiovascular risk factors in end-stage renal disease. J Am Soc Nephrol 2004;15:577-580.
3. Endemann DF, Schiffrin E: Endothelial Dysfunction. J Am Soc Nephrol 2004;15:1983-1992.
4. Perticone F, Maio R, Tripepi G, Zoccali C: Endothelial dysfunction and mild renal insufficiency in essential hypertension. Circulation 2004;110:821-825.
5. Moe SM, Chen N: Pathophysiology of vascular calcification in chronic kidney disease. Circ Res 2004;95:560-567.
6. Floege J, Ketteler M: Vascular calcification in patients with end-stage renal disease. Nephrol Dial Transplant 2004;19(suppl 5):59-66.
7. Nigam A, Mitchell GF, Lambert J, Tardif JC: Relation between conduit vessel stiffness (assessed by tonometry) and endothelial function (assessed by flow-mediated dilatation) in patients with and without coronary artery disease. Am J Cardiol 2003;92:395-399.
8. Budoff MJ, Flores F, Tsai J: Measures of brachial artery distensibility in relation to coronary calcification. Am J Hypertens 2003;16:350-355.
9. Huang PH, Chen LC, Leu HB, Ding PY, Chen JW, Wu TC: Enhanced coronary calcification determined by electron beam CT is strongly related to endothelial dysfunction in patients with suspected coronary artery disease. Chest 2005;128:810-815.
10. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002;39:S1-S266.
11. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate estimate of glomerular filtration rate from serum creatinine: a new prediction equition. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470.
12. Celermajer DS, Sorensen KE, Gooch VM: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-1115.
13. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R: Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986;74:1399-1406.
14. Clarkson P, Celermajer DS, Powe AJ, Donald AE, Henry RM, Deanfield JE: Endothelium-dependent dilatation is impaired in young healthy subjects with a family history of premature coronary disease. Circulation 1997;6:3378-3383.
15. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A: Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000;101:948-954.
16. Thambyrajah J, Landray MJ, McGlynn FJ, Jones HJ, Wheeler DC, Townend JN: Abnormalities of endothelial function in patients with predialysis renal failure. Heart 2000;83:205-209.
17. Yildiz A, Oflaz H, Pusuroglu H, Mercanoglu F, Genchallac H, Akkaya V: Left ventricular hypertrophy and endothelial dysfunction in chronic hemodialysis patients. Am J Kidney Dis 2003;41:616-623.
18. Ketteler M: Fetuin-A and extraosseous calcifications in uremia. Curr Opin Nephrol Hypertens 2005;14:337-342.
19. Moe SM, Reslerova M, Ketteler M, O'Neill K, Duan D, Koczman J: Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 2005;67:2295-2304.
20. 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003;112:357-366.
21. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Bohm R: Association of low fetuin-A (AHSG) concentration in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003;361:827-833.
22. Stenvinkel P, Wang K, Qureshi AR, Axelsson J, Pecoits-Filho R, Gao P: Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin. Kidney Int 2005;67:2383-2392.
23. Ix JH, Chertow GM, Shlipak MG, Brandenburg VM, Ketteler M, Whooley MA: Fetuin-A and kidney function in persons with coronary artery disease: data from Heart and Soul Study. Nephrol Dial Transplant 2006;21:2144-2151.
24. Mehrotra R, Westenfeld R, Christenson P, Budoff M, Ipp E, Takasu J: Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification. Kidney Int 2005;67:1070-1077.
25. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001;38:938-942.
26. Reynolds JL, Joannides AJ, Skepper JN, Mc-Nair R, Schurgers LJ, Proudfoot D: Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracelluler calcium and phosphate concentrations: A potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004;15:2587-2867.
27. Cola C, Almeida M, Li D, Romeo F, Mehta JL: Regulatory role of endothelium in the expression of genes affecting arterial calcification. Biochem Biophys Res Commun 2004;320:424-427.
28. Ombrellino M, Wang H, Yang H, Zhang M, Vishnubhakat J, Frazier A: Fetuin, a negative acute phase protein, attenuates TNF synthesis. Shock 2001;15:181-185.
29. Martens FM, Rabelink TJ, op't Roodt J, de Koning EJ, Visseren FL: TNF-α induces endothelial dysfunction in diabetic adults, an effect reversible by the PPAR-γ agonist pioglitazone. Eur Heart J 2006;27: 1605-1609.
30. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr: Carotid artery intima-media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999;340:14-22.
31. Benedetto FA, Mallamaci M, Tripepi G, Zoccali C: Prognostic value of ultrasonographic measurement of carotid intima-media thickness in dialysis patients. J Am Soc Nephrol 2001;12:2458-2464.
32. Zoccali C, Benedetto FA, Maas R, Mallamaci M, Tripepi G, Malatino LS: Asymmetric dimethyl arginine, C-reactive protein and carotid intima-media thickness in end stage renal disease. J Am Soc Nephrol 2002;13:490-496.